INVESTINGAcceleron Soars in After-Hours Trading on Positive Trial Results for Hypertension TreatmentBy Tom BemisJan 27, 2020 5:37 PM EST
PRESS RELEASESBehind The Seizure® Program Further Expands Access To Genetic Testing For Children To Speed The Diagnosis Of Genetic EpilepsyBy PR NewswireJan 8, 2020 2:30 AM EST
INVESTINGBristol-Myers, Gilead, Biogen, Other Drugmakers Increased U.S. List Prices on Jan. 1: ReportBy Rob LenihanJan 2, 2020 1:41 PM EST
INVESTINGBiogen Shares Up After Alzheimer Drug Tests Show No New ConcernsBy Rob LenihanDec 5, 2019 1:15 PM EST
FUTURESOPEC, Huawei, PG&E, Biogen, and a 2020 Recession? - 5 Things You Must KnowBy M. Corey GoldmanDec 5, 2019 7:00 AM EST
JIM CRAMERCaterpillar, Amgen, Biogen Idec: 'Mad Money' Lightning RoundBy Scott RuttDec 2, 2019 8:39 PM EST
INVESTINGStocks End Lower as Travelers, McDonald's Miss Earnings ForecastsBy Rob LenihanOct 22, 2019 4:27 PM EDT
INVESTINGIs Biogen Stock a Buy or Sell After Tuesday's Choppy Rally?By Bret KenwellOct 22, 2019 1:38 PM EDT
MARKETSBiogen Surges After Announcing Plans to Pursue Alzheimer's Drug ApprovalBy Brenda BouwOct 22, 2019 11:39 AM EDT
VIDEOIt's Earnings Season! Jim Cramer on McDonald's, Beyond Meat and WeWorkBy Katherine RossOct 22, 2019 9:20 AM EDT
STOCKSDow Futures Slip After McDonald's Earnings; US-China Trade Hopes Boost SentimentBy Martin BaccardaxOct 22, 2019 8:20 AM EDT
MARKETSMcDonald's, Procter & Gamble, Chevron, WeWork, Snap - 5 Things You Must KnowBy Joseph WoelfelOct 22, 2019 6:23 AM EDT
STOCKSBiogen Rises After Canceling Two Late-Stage Alzheimer's TrialsBy Tony OwusuSep 13, 2019 9:32 AM EDT
EARNINGSBiogen Shares Jump on Strong Second-Quarter EarningsBy M. Corey GoldmanJul 23, 2019 9:36 AM EDT
MARKETSApple, Coca-Cola, Snap, Facebook, Debt Ceiling - 5 Things You Must KnowBy Joseph WoelfelJul 23, 2019 7:20 AM EDT
